Cargando…
Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage
BACKGROUND: Metastatic castration-resistant prostate cancer (CRPC) is the leading cause of death among men diagnosed with prostate cancer. Piperlongumine (PL) is a novel potential anticancer agent that has been demonstrated to exhibit anticancer efficacy against prostate cancer cells. However, the e...
Autores principales: | Zhang, Ding-fang, Yang, Zhi-chun, Chen, Jian-qiang, Jin, Xiang-xiang, Qiu, Yin-da, Chen, Xiao-jing, Shi, Hong-yi, Liu, Zhi-guo, Wang, Min-shan, Liang, Guang, Zheng, Xiao-hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261967/ https://www.ncbi.nlm.nih.gov/pubmed/34229670 http://dx.doi.org/10.1186/s12906-021-03369-0 |
Ejemplares similares
-
Identification of Piperlongumine as Potent Inhibitor of Necroptosis
por: He, Xiaoyan, et al.
Publicado: (2023) -
Piperlongumine Inhibits Migration of Glioblastoma Cells via Activation of ROS-Dependent p38 and JNK Signaling Pathways
por: Liu, Qian Rong, et al.
Publicado: (2014) -
Survivin Promotes Piperlongumine Resistance in Ovarian Cancer
por: Nan, Xing-Wei, et al.
Publicado: (2019) -
Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells
por: Gong, Li-Hua, et al.
Publicado: (2014) -
Preformulation Studies on Piperlongumine
por: Aodah, Alhassan, et al.
Publicado: (2016)